Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by winr88on Feb 08, 2022 12:02pm
499 Views
Post# 34408913

With Dr Vera Madzarevic leading the clinical trials

With Dr Vera Madzarevic leading the clinical trialsReading her credentials here I feel very confident she will more than correct any past Theralase clinical trial mistakes and lead the company into a highly successful treatment for cancer.

Dr. Madzarevic has more than twenty five years of experience in global pharmaceutical research, development and academic research. Trained as a medical scientist, she has held academic and industry positions internationally. Her areas of expertise include discovery, pre-clinical, clinical and post-marketing development. Vera has worked for world renowned pharmaceutical companies such as Ciba-Geigy in Canada and globally, as well as Novartis in East Hannover in the US as a Senior Scientist. Dr. Madzarevic completed her post-doctoral research fellowship at the Banting and Best Institute for Medical Research at the University of Toronto.

Her vast experience includes providing consultancy services for most major pharmaceutical and biotech companies across the globe. Vera´s particular expertise is centered on internal and pre-regulatory GCP, GLP, and CLIA pre-certification inspections, clinical trial management, drug development programs, quality assurance, and professional training. She currently heads the following companies: Global Research Pharma Canada, EduPharma Canada and the Clinical Research Institute of America . Vera was also the main coordinator of the Clinical Research Diploma Program (post graduate program in clinical research) at the Academy of Applied Pharmaceutical Sciences in Toronto, Canada. Vera is a published author, with her last work being Clinical Trials Audit Preparation: A Guide for Good Clinical Practice (GCP) Inspections by Vera Mihajlovic-Madzarevic (Wiley, 2010),

<< Previous
Bullboard Posts
Next >>